baber/WOPTO huggingface dataset:
Patent CA-2538826-A1 (CA)
Inventor: MILLER CARY JAMES
IPC: G01N33/543
Filed: 2004-09-09
Abstract: An electrochemical immunosensor system with reduced interference, comprising:  a first immunosensor that generates an electrochemical signal based on the formation of a sandwich between an immobilized antibody, a target analyte and a labeled antibody, wherein a portion of the signal arises from non-specific binding of the labeled antibody in the region of the first immunosensor, and a second immunosensor that acts as an immuno-reference sensor and generates a signal that is the same as or predictably related to the degree of non-specific binding which occurs in the region of the first immunosensor, and has an immunocomplex between an immobilized antibody and an endogenous or exogenous protein that is in the sample and that is not the target analyte.
Patent CA-2540613-A1 (CA)
Title: Use of an intumescent material and device comprising such a material
Inventor: SCHNEKENBURGER RUDOLF
IPC: A62C2/24
Filed: 2004-10-08
Abstract: The invention relates to the use of an intumescent material as a sensor, actuator or fixing means for movable elements in the field of fire and smoke protection.
Patent CA-2541397-A1 (CA)
Inventor: PEDERSEN PETER S
IPC: B01J8/00
Filed: 2004-10-07
Abstract: An arrangement of cooling tubes within a Fischer-Tropsch slurry reactor simplifies removal and reinstallation of cooling tubes for reactor maintenance.
Patent CA-2541479-A1 (CA)
Title: Vapour deposition method
Inventor: HAYDEN BRIAN ELLIOTT
IPC: B01J19/00
Filed: 2004-10-08
Abstract: In a vapour deposition method which can be used to deposit mixtures of materials in progressively varying amounts on a substrate (1) and which can be used for a variety of purposes, but is of especial value in combinatorial chemistry, the path of the vaporised material from the source (3) to the substrate (1) is partially interrupted by a mask (5), the positioning of the mask in a plane parallel to the plane defined by the substrate (1) being such that the material is deposited on the substrate (1) in a thickness which increases substantially continuously in a direction along the substrate (1).
Patent CA-2541882-A1 (CA)
Title: Procede et systeme d'ionisation par decharge luminescente et nebulisation
Inventor: SUZUKI SHIGERU
IPC: G01N27/62
Filed: 2003-11-21
Abstract: L'invention concerne un procédé et un système d'ionisation par décharge luminescente et nébulisation pouvant compléter ou remplacer un procédé d'ionisation principal de spectrométrie de masse, tel qu'un procédé d'ionisation chimique à pression atmosphérique (APCI), et ou un procédé d'ionisation par électronébulisation (ESI), et permettant de renforcer l'efficacité de l'ionisation avec un gaz présentant un effet Penning. Ce système d'ionisation par décharge luminescente et nébulisation comprend une entrée (A) permettant l'introduction d'un fluide contenant un composé à mesurer, un entrée (B) entourant l'entrée (A), qui permet de souffler un gaz présentant un effet Penning et de nébuliser le fluide entrant par l'entrée (A), une électrode (E) de décharge côté terre placée au niveau d'une entrée (C), générant le flux de nébulisation, et une électrode (F) de décharge côté application de tension installée dans la direction d'entraînement du flux de nébulisation. Le fluide est ionisé dans un gaz atomisé (1) à effet Penning, excité par le composé devant être mesuré lors de la nébulisation de ce dernier dans le gaz atomisé (1) à effet Penning, puis le fluide est soumis à une spectrométrie de masse.
Patent CA-2542362-A1 (CA)
Title: Expandible surgical access device
Inventor: SMITH ROBERT C
IPC: A61M29/00
Filed: 2004-10-15
Abstract: An access device for facilitating access to a surgical site includes an access member defining a longitudinal axis and having proximal and distal ends. The access member includes an inner member and an outer member disposed about the inner member. The inner member defines an opening therethrough to permit access to a surgical site and is moveable relative to the outer member. The access device also includes a deployment member associated with the inner member and the outer member. The deployment member is adapted to be deployed in at least a radial outward direction relative to the longitudinal axis upon movement of the inner member relative to the outer member, to thereby be positioned to engage body tissue to facilitate retention of the access member within a patient's body. The deployment member comprises a collar engaged with the inner member at a first end portion and the outer member at a second end portion.
Patent CA-2544644-A1 (CA)
Title: Cling film laminate structure
Inventor: SAJOT NICOLAS EDGARD
IPC: B32B7/10
Filed: 2004-11-04
Abstract: A cling film laminate structure, a process for making the laminate, and use of the laminate in a fastening system for various goods is disclosed. The laminate is composed of a cling layer having autoadhesive surface properties bonded to a substantially non-stretchable carrier layer. The carrier layer is formed of a material which eliminates, or substantially limits, stretching of the cling layer. An ethylene-based or propylene-based metallocene or single site catalyzed polyolefin provides the autoadhesive surface properties for the cling layer. Preferably, the carrier layer is comprised of a nonwoven material, or a thermoplastic film. A laminate composed of a cling layer and a non-stretchable carrier layer is particularly useful as a fastening system for a package, envelope, tape or disposable soft goods article.
Patent CA-2545463-A1 (CA)
Title: Contenant d'infusion pour the ou analogue comprenant une enveloppe et un sachet d'infusion
Inventor: KLINAR MIHA
IPC: B65D85/812
Filed: 2003-11-17
Abstract: L'invention concerne un dispositif (1) destiné à préparer une boisson à partir d'extraits, notamment d'extraits de thé, et comprenant au moins un contenant (5) pour mélange extractible au moins partiellement perméable au liquide, ainsi qu'une enveloppe (2) reliée audit contenant (5). L'invention concerne également une enveloppe (2) utilisée dans ce dispositif (1). Elle se rapporte en outre à un contenant (5) utilisé dans ce dispositif.
Patent CA-2551046-A1 (CA)
Inventor: INNEREBNER FEDERICO
IPC: A23L19/18
Filed: 2004-12-17
Abstract: The invention relates to a starch product in the form of a foodstuff ingredient and to a foodstuff per se whose hydrolysis speed during digestion can be set to low and especially almost constant in that the starch is obtained as a partially crystalline network with a low degree of swelling by means of targeted conditioning, starting from an at least partly amorphous state.
Patent CA-2551225-A1 (CA)
Title: Method and device for providing a defined fluid flow, especially for use in liquid chromatography
Inventor: HOCHGRAEBER HERMANN
IPC: G01N30/32
Filed: 2004-11-23
Abstract: The invention relates to a method for providing a defined fluid flow, especially for use in liquid chromatography. According to the method, a constant total flow (f0) is subdivided into an internal excess flow (fie) in an excess branch and into an internal working flow (fiw) in a working branch.  The ratio of subdivision of the internal working flow (fiw) and the internal excess flow (fie) depends on the reverse ratio of a fluidic resistance provided in the working branch and a fluidic resistance in the excess branch.  The excess branch and the working branch are interlinked at the respective outputs of the two fluidic outputs of the fluidic resistances by a cross-branch. The equalizing flow occurring between the outputs of the fluidic resistances is measured by means of a flow sensor. A desired, external working flow in the further course of the working branch can be fed to a working device, for example a chromatography column mounted downstream of the device.  Further down the excess branch a variable fluidic resistance device is arranged. The resistance value of the variable fluidic resistance device is controlled, thereby controlling the equalizing flow in such a manner that the equalizing flow, preferably in the temporal mean, is substantially zero or equals a defined offset value whose amount is small compared to the internal working flow (fiw). The invention also relates to a device for carrying out the inventive method.
Patent CA-2551897-A1 (CA)
Title: A remote commander
Inventor: YAN ZHENGHUA
IPC: H04N5/44
Filed: 2006-07-13
Abstract: A remote commander is provided including a main body; a main processor module; a transmitter module and a receiver module; a processing unit and a storage module; function keys connected with and be controlled by the processing unit;  a transmitting element and a receiving element; power supply positioned on the back of the case. The remote commander further comprises a handgrip processing module connected to the main processor module; a remote control handgrip connected to the handgrip processing. module; and an encrypting code identification module connected to the main processor module. An encrypting code identification key is positioned on the main body and is connected to the encrypting code identification module.  The remote commander operates to fulfill operational functions while providing higher security.
Patent CA-2554473-A1 (CA)
Inventor: MAKOFSKY MARVIN A
IPC: B42F7/08
Filed: 2006-07-28
Abstract: The pocket folder has a closed pocket on the back section with each side of the closed pocket being freely expandable. Flaps that form the ends of the closed pocket are separated by a fold line into two contiguous parts that are hinged to each other to allow expansion of the pocket. The pocket folder is fabricated from a one--piece blank of any suitable material such as paper, paperboard or plastic and has score lines on at least the back section to permit expansion when materials are inserted into the closed pocket.
Patent CA-2555245-A1 (CA)
Title: Antisense oligonucleotide modulation of stat3 expression
Inventor: KARRAS JAMES G
IPC: A61P43/00
Filed: 2004-09-30
Abstract: Compounds, compositions and methods are provided for inhibiting the expression of human STAT3. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding STAT3. Methods of using these oligonucleotides for inhibition of STAT3 expression and for promotion of apoptosis are provided. Methods for treatment of diseases, particularly inflammatory diseases and cancers, associated with overexpression or constitutive activation of STAT3 or insufficient apoptosis are also provided.
Patent CA-2557425-A1 (CA)
Inventor: LORD ANDREW
IPC: H04L25/03
Filed: 2005-03-30
Abstract: The present invention relates to a communication system having a central station and a plurality of outstations. The central station is configured to execute a compensation procedure for compensating for degradation of data from the outstations, the compensation procedure having a plurality of adjustable characteristics, which characteristics are governed by a parameter set. The central station stores a respective parameter set in respect of each outstation; and, for each outstation, applies the compensation algorithm to data from that outstation using the parameter set associated with that outstation. In an initialization phase, the central station tests a plurality of starting parameter sets on data from a given outstation and selects the set providing the best compensation. The selected set is stored for subsequent compensation of data from that outstation.
Patent CA-2557905-A1 (CA)
Title: Process for coating vehicle exterior parts comprising polyamide resins and parts and articles coated thereby
Inventor: RENKEN ANDREAS
IPC: B05D1/04
Filed: 2005-03-28
Abstract: Process for coating vehicle exterior parts comprising polyamide compositions comprising polyamide, novolac resin, and toughener. The polyamide compositions may further comprise mineral fillers, nucleating agents, and other additives.  Articles coated according to the process herein are also disclosed.
Patent CA-2560914-A1 (CA)
Title: Method for purifying co2 gasflow
Inventor: KOERFER MARTIN
IPC: C07C319/20
Filed: 2005-07-07
Abstract: The invention relates to a method for purifying CO2 exhaust gas flow in order to remove chemical compounds and for returning purified gas flows to a production process, in particular to a methyonine production process, wherein said gas is exposed to the following operations consisting a) in dissolving the gas in water or in water in methylmercapto-propionaldehyd (MMP) maximum up to solubility limit, b) in consequently washing the gas with MPP, c) in washing in water and, afterwards d) in returning the thus purified CO2 to the production process.
Patent CA-2562418-A1 (CA)
Inventor: WOO JONG-SOO
IPC: A61P9/10
Filed: 2005-04-08
Abstract: The sustained release formulation for oral administration of an HMG-CoA  reductase inhibitor of the present invention can be easily and economically prepared and is capable of maintaining a constant drug level in blood by slowly releasing the HMG-CoA reductase inhibitor at a uniform rate for 24 hrs.  Accordingly, the sustained release formulation of the present invention can be effectively used for lowering blood cholesterol and triglyceride levels.
Patent CA-2562483-A1 (CA)
Title: Long-wearing cosmetic compositions
Inventor: SUNKEL JORGE MAX
IPC: A61K8/88
Filed: 2005-04-29
Abstract: A cosmetic composition comprising: (A) at least one structured aqueous polymeric adhesive phase comprising: i) at least one aqueous dispersion of adhesive film-forming polymer particles; and ii) at least one structuring agent in an amount effective to viscoelastically thicken, but not solidify, the structured aqueous polymeric adhesive phase; and (B) at least one fatty phase comprising at least one lipidic component wherein (A) is compatible when combined with (B) to form a long-wearing cosmetic composition such that the viscosity of the long-wearing cosmetic composition is greater than the viscosity of (B) alone and the tan .delta. value of the long-wearing cosmetic composition is less than the tan .delta. value of (B) alone.
Patent CA-2563735-A1 (CA)
Inventor: JAKOBOVITS AYA
IPC: A61K39/00
Filed: 2004-04-22
Abstract: Antibodies and molecules derived therefrom that bind to novel STEAP-1 protein, and variants thereof, are described wherein STEAP-1 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, STEAP-1 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The STEAP-1 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with STEAP-1 can be used in active or passive immunization.
Patent CA-2564553-A1 (CA)
Inventor: ARMSTRONG DANIEL A
IPC: F16L5/14
Filed: 2006-10-18
Abstract: Provided is a cord seal for use in an underwater niche that comprises a seal cap and a main seal having a front side and a rear side and the main seal further includes a plurality of apertures that extend from the front side to the rear side. The cord seal can accommodate cords of two different sizes. The main seal also includes a plurality of splits to make it easier to install the cords. The main seal deforms to provide a water-tight seal despite the presence of at least one split in the main seal. In one embodiment, additional support structures are provided including a front seal support and a rear seal support. The front seal support has a plurality of projections that extend through the main seal and the rear seal support to connect each of the structures. The projections can be used to help spread apart the seal when it is desired to remove and replace a light assembly.
Patent CA-2564952-A1 (CA)
Title: Novel indole derivatives as selective androgen receptor modulators (sarms)
Inventor: LANTER JAMES C
IPC: A61K31/381
Filed: 2005-04-01
Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. Formula (II): (II)
Patent CA-2565209-A1 (CA)
Inventor: MISHRA SHRIKANT
IPC: C07K14/61
Filed: 2004-11-09
Abstract: Adding enough organic solvent to hydrophobic interactive chromatography elution buffer eliminates the need to also add detergent to the buffer when separating poly-peptides. For example, adding about 50% acetonitrile to detergent-free elution buffer enaibls one to separate full-length human growth hormone from its various truncated forms, to obtain hGH with a purity of >99.5%. This technique is useful to purify polypeptide where detergent to contamination in the resulting polypeptide is undesirable.
Patent CA-2565320-A1 (CA)
Inventor: VAN DER MOERE DONALD R
IPC: B22F7/06
Filed: 2005-05-17
Abstract: A connecting rod unitarily formed in a powder metallurgy process provides a non-homogenous structure. The connecting rod has a piston end, a crankshaft end, and an interconnecting shank. The piston end, the crankshaft end, and the interconnecting shank are formed of a structural material.
Patent CA-2566194-A1 (CA)
Inventor: BRACE KAREN MARIE
IPC: H01M4/38
Filed: 2005-04-13
Abstract: Titanium dioxide or a lithium titanate, especially mesoporous titanium dioxide or lithium titanate, can function as a negative electrode in an electrochemical cell in which the electrolyte is an aqueous solution containing lithium and hydroxide ions.
Patent CA-2566228-A1 (CA)
Inventor: JORGEN KARLSEN
IPC: A61P35/00
Filed: 2005-05-10
Abstract: The present invention provides a method of tonic treatment of an aging mammalian subject, or a subject suffering from mild inflammation, lupus, fatigue, lethargy or the aftereffects of infection, disease or treatment, comprising administration of a compound of formula (I) or a salt thereof. Said compounds are also used as a support to another drug and/or treatment regime especially a method for the treatment of a viral, autoimmune, hyperplastic or neoplastic disease, and for the prevention of diseases associated with old age including arthritis (especially RA), Alzheimer~s, Parkinson~s and Huntington~s diseases, cancer or other neoplastic disease.
Patent CA-2566758-A1 (CA)
Inventor: EPPIG CHRISTOPHER P
IPC: C10B57/06
Filed: 2005-05-12
Abstract: A delayed coking process for making substantially free-flowing coke, preferably shot coke. A coker feedstock, such as a vacuum residuum, is heated in a heating zone to coking temperatures then conducted to a coking zone wherein volatiles are collected overhead and coke is formed. A low molecular weight additive is added to the feedstock prior to it being heated in the heating zone, prior to its being conducted to the coking zone, or both.
Patent CA-2567675-A1 (CA)
Inventor: KRAEMER UWE
IPC: A61B5/151
Filed: 2006-11-09
Abstract: The invention concerns a system for analysing a sample liquid comprising a test tape (12) having a plurality of test elements (14), a tape transport device (16) which successively transports the test elements (14) to a sample application site (34) while advancing the tape and a measuring device (18) which scans the test elements (14) loaded with sample liquid at a measuring site (36) wherein the measuring site (36) is located at a distance from the sample application site (34) in the direction of tape movement. According to the invention it is proposed that the tape transport be interrupted in order to exactly position a wetting area (42) of the test elements (14) carrying a sample liquid at the measuring site (36) by means of a positioning device (20) that responds to the presence of sample liquid on the test element (14).
Patent CA-2567741-A1 (CA)
Title: Self-assembling nanoparticle drug delivery system
Inventor: OH KENNETH J
IPC: A61K9/127
Filed: 2005-05-25
Abstract: A self-assembling nanoparticle drug delivery system for the delivery of drugs including peptides, proteins, nucleic acids or synthetic chemical drugs is provided. The self-assembling nanoparticle drug delivery system described herein includes viral capsid proteins, such as Hepatitis B Virus core protein, encapsulating the drug, a lipid bi-layer envelope and targeting or facilitating molecules anchored in the lipid bilayer. A method for construction of the self-assembling nanocparticle drug delivery system is also provided.
Patent CA-2568626-A1 (CA)
Inventor: GODWIN HAROLD
IPC: B22D17/20
Filed: 2005-05-17
Abstract: A seal for a check valve for a metal molding machine. The seal is provided by the combination of a peripheral groove in an outer surface of the check valve and a helically wound core in the groove. The helically wound coil is expandable into sealing engagement with a cylindrical wall of the molding machine. The helically wound coil may be movable laterally in the groove between a melt channel open position and a melt channel closed position to open or seal the melt channel.
Patent CA-2568729-A1 (CA)
Title: Biomarkers for the prediction of responsiveness to clozapine treatment
Inventor: HE YUNSHENG
IPC: C12Q1/68
Filed: 2005-06-03
Abstract: This invention provides methods to predict the likelihood of suicidal or self-destructive behaviour in a patient during treatment. The method employs the detection of a VNTR polymorphism in the 3'-UTR of the dopamine transporter gene (SLC6A3). Patients with nine or fewer repeats are considered poor responders to clozapine. Nine or fewer repeats in the SLC6A3 gene have been correlated with poor expression of the SLC6A3 gene. Also provided are methods of treatment based on the presence or absence of this polymorphism or surrogate markers thereof. Also provided are kits to use in the methods of the invention.
Patent CA-2573259-A1 (CA)
Title: High affinity anti-tnf-alpha antibodies and method
Inventor: RAJPAL ARVIND
IPC: A61K39/395
Filed: 2005-07-06
Abstract: An isolated human anti-TNF-.alpha. antibody, or antigen-binding portion thereof, containing at least one high-affinity VL or VH antibody chain that is effective, when substituted for the corresponding VL or VH chain of the anti-TNF~-.alpha. scFv antibody having sequence SEQ ID NO: 1, to bind to human TNF-.alpha. with a Koff rate constant that is at least 1.5 fold lower than that of the antibody having SEQ ID NO: 1, when determined under identical conditions.
Patent CA-2574571-A1 (CA)
Inventor: LIU ZHENGUO
IPC: C08L67/02
Filed: 2005-08-17
Abstract: The present invention relates to a melt blend of a base polymer, an oxidizable organic polymer, a transition metal salt catalyst and a colorant that does not completely deactivate the catalyzed oxidation. A preferred colorant, yields in an article made from the polymer melt blend a Catalyst Deactivation Factor (CDF) of less than about 0.25, preferably less than 0.15, more preferably less than 0.1, and most preferred less than 0.05. The present invention also comprises a colored monolayer article having the described CDF, such as a film, thermoformed tray, or blow molded container, that has active oxygen scavenging properties. The colorant, after melt blending a base polymer, an oxidizable organic polymer, a transition metal catalyst, does not increase the binding energy of the transition metal catalyst ion by more than 1 eV.
Patent CA-2577741-A1 (CA)
Title: Determining data quality and/or segmental aneusomy using a computer system
Inventor: PIPER JAMES RICHARD
IPC: G16B20/10
Filed: 2005-08-18
Abstract: A method and/or system for making determinations regarding samples from biologic sources including statistical methods for making meaning grouping of observed data and/or for determining an overall quality measure of an assay.